Repligen RGEN
NASDAQ RGEN
$178.16 +5.25 (+3.04%)
As of: Sep 17, 2026 · 3:59 PM EDT

Repligen (RGEN) Sales of Property, Plant and Equipment (2022 - 2025)

Analysis

Repligen (RGEN) Sales of Property, Plant and Equipment (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 4.00 Mn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn -
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 3.04 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -100,000.00
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 196,000.00
Mar 31, 2025 42,000.00
Dec 31, 2024 -1.29 Mn
Sep 30, 2024 1.28 Mn
Mar 31, 2024 11,000.00
Dec 31, 2023 -21,000.00
Mar 31, 2022 17,000.00